TMEM128: A Potential Drug Target and Biomarker for Cancer and Neurodegenerative Diseases

Target Name: TMEM128

NCBI ID: G85013

TMEM128: A Potential Drug Target and Biomarker for Cancer and Neurodegenerative Diseases

TMEM128 (Tissue Membrane Expansion Module 128) is a protein that is expressed in various tissues and organs throughout the body. It is a key component of the intercellular junctions, which are vital for maintaining tissue structure and function. TMEM128 has been identified as a potential drug target and has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

TMEM128 is a transmembrane protein that is expressed in the endoplasmic reticulum and cytoplasm of various cell types. It is composed of two distinct regions: an N-terminus that is involved in the formation of the intercellular junctions, and a C-terminus that is involved in the regulation of cell signaling pathways. The N-terminus of TMEM128 contains a region that is highly conserved and is involved in the formation of the intercellular junctions. This region is known as the N-end rule (NER) and is a common feature of proteins that are involved in cell signaling pathways.

The C-terminus of TMEM128 contains a region that is involved in the regulation of cell signaling pathways. This region is known as the C-end rule (CER) and is also a common feature of proteins that are involved in cell signaling pathways. The CER region of TMEM128 contains a variety of conserved motifs that are involved in the regulation of cell signaling pathways.

TMEM128 has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that TMEM128 is involved in the regulation of cell signaling pathways that are involved in the development and progression of cancer. Additionally, TMEM128 has been shown to play a role in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its role in disease, TMEM128 has also been shown to be a potential drug target. Studies have shown that TMEM128 can be targeted by small molecules and antibodies, and that these treatments can inhibit the activity of TMEM128. Additionally, TMEM128 has been shown to interact with a variety of different proteins, including TGF-β1, PDGF, and NF-kappa-B. These interactions may be important for the regulation of cell signaling pathways and could be potential drug targets.

TMEM128 is also a potential biomarker for a variety of diseases. For example, studies have shown that TMEM128 levels are elevated in a variety of cancer tissues and that these levels can be used as a biomarker for the diagnosis and prognosis of cancer. Additionally, TMEM128 levels have been shown to be elevated in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and these levels can be used as a biomarker for the diagnosis and prognosis of these diseases.

In conclusion, TMEM128 is a protein that is expressed in various tissues and organs throughout the body and has been shown to play a role in the regulation of cell signaling pathways. It is also a potential drug target and has been identified as a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of TMEM128 in these diseases and to develop effective treatments.

Protein Name: Transmembrane Protein 128

More Common Targets